- Home
- Books
- An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy
- Chapter
Nanotechnology Impact and It’s Future Perspectives on COVID-19 Therapy
- Authors: Anitha Sriram1, Rahul Kumar2, Indrani Maji3, Dharmendra Kumar Khatri4, Shashi Bala Singh5, Saurabh Srivastava6, Pankaj Kumar Singh7
-
View Affiliations Hide AffiliationsAffiliations: 1 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 2 Department of Biological Sciences, National Institute of Pharmaceutical Education andResearch (NIPER), Hyderabad, India 3 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 4 Department of Biological Sciences, National Institute of Pharmaceutical Education andResearch (NIPER), Hyderabad, India 5 Department of Biological Sciences, National Institute of Pharmaceutical Education andResearch (NIPER), Hyderabad, India 6 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 7 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India
- Source: An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy , pp 192-203
- Publication Date: August 2022
- Language: English
Nanotechnology Impact and It’s Future Perspectives on COVID-19 Therapy, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815039863/chap9-1.gif
Nanoscience deals with the study of materials at nanoscale dimensions. It has been shown that modernizing drugs to a nanosized delivery system will afford fruitful outcomes with enhanced efficacy against the virus, reduction of the drug dose and improved targetability with enhanced/sustained bioavailability, If the drug dose is reduced, the dose-related side effects are reduced. Dose reduction through nanotechnology also limits non-target tissue toxicity. Hence, nanotechnology has remarkable potential in the pharmaceutical industry. Due to their small molecular level of tunable size, nanopharmaceuticals (in the form of nanoparticles) will easily enter the cells or tissues. The case of COVID-19, they interact with the virus and act accordingly and might inhibit the viral processes of 2019nCoV in COVID-19. nbsp;
-
From This Site
/content/books/9789815039863.chap9dcterms_subject,pub_keyword-contentType:Journal105
